[HTML][HTML] Fabrication of active targeting lipid nanoparticles: Challenges and perspectives

I Menon, M Zaroudi, Y Zhang, E Aisenbrey… - Materials Today Advances, 2022 - Elsevier
Targeted drug and gene delivery is the key for precision therapy. Lipid nanoparticles as non-
viral vectors have attracted extensive attentions in treating a variety of diseases, such as …

Aptamer-functionalized liposomes for targeted cancer therapy

SA Moosavian, P Kesharwani, V Singh… - … Nanocarriers for Cancer …, 2023 - Elsevier
Liposomes are among the most well-documented drug delivery systems in anticancer
therapy owing to their passive targeting capacities besides inherent biocompatibility and …

A landscape of recent advances in lipid nanoparticles and their translational potential for the treatment of solid tumors

RA Paun, S Jurchuk, M Tabrizian - … & Translational Medicine, 2024 - Wiley Online Library
Lipid nanoparticles (LNPs) are biocompatible drug delivery systems that have found
numerous applications in medicine. Their versatile nature enables the encapsulation and …

siRNA and targeted delivery systems in breast cancer therapy

S Mirzaei, MDA Paskeh, M Entezari, SH Bidooki… - Clinical and …, 2023 - Springer
Recently, nucleic acid drugs have been considered as promising candidates in treatment of
various diseases, especially cancer. Because of developing resistance to conventional …

Clinical use and future perspective of aptamers

E Esawi, H Nsairat, IS Mahmoud, Z Lafi… - … Nanocarriers for Cancer …, 2023 - Elsevier
Aptamers are a unique class of nucleic acid molecules currently being investigated for
clinical applications. Aptamers are functional single-stranded oligonucleotides able to form …

Activation of cancer immunotherapy by nanomedicine

L Wang, H Xu, L Weng, J Sun, Y Jin… - Frontiers in …, 2022 - frontiersin.org
Cancer is one of the most difficult diseases to be treated in the world. Immunotherapy has
made great strides in cancer treatment in recent years, and several tumor immunotherapy …

Aptamers Targeting the PD-1/PD-L1 Axis: A Perspective

P Bertrand - Journal of Medicinal Chemistry, 2023 - ACS Publications
Aptamers have emerged in recent years as alternatives to antibodies or small molecules to
interfere with the immune check points by blocking the PD-1/PD-L1 interactions and …

Cancer immunotherapy via nucleic acid aptamers

F Zahedipour, M Majeed, P Kesharwani… - … Nanocarriers for Cancer …, 2023 - Elsevier
Immunotherapy has transformed cancer care in the last decade. Aptamers are single-
stranded RNA or DNA oligonucleotides having three-dimensional folding structures …

Aptamer-based immune drug systems (AptIDCs) potentiating cancer immunotherapy

H Xiong, L Liu, X Liu, H Jiang, X Wang - Chemistry, 2023 - mdpi.com
Aptamers are artificial oligonucleotides with excellent molecule-targeting ability. Compared
with monoclonal antibodies, aptamers have the advantages of low cost, no batch effect, and …

[HTML][HTML] Potential of Lipid Based Nanodrug Carriers for Targeted Treatment of Glioblastoma: Recent Progress and Challenges Ahead

BS Satpathy, B Barik, LA Kumar… - Glioblastoma-Current …, 2022 - intechopen.com
Malignant brain tumor at its fourth stage (glioblastoma) is the most dangerous and an
unsolved medical challenge till today. Present therapeutic strategies including chemo …